The Research Equity and Diversity Initiative (READI): Changing the face of clinical research through community outreach and engagement
Date
2025-01-01
Journal Title
Journal ISSN
Volume Title
Repository Usage Stats
views
downloads
Citation Stats
Attention Stats
Abstract
Current evidence underscores a need to transform how we do clinical research, shifting from academic-driven priorities to co-led community partnership focused programs, accessible and relevant career pathway programs that expand opportunities for career development, and design of trainings and practices to develop cultural competence among research teams. Failures of equitable research translation contribute to health disparities. Drivers of this failed translation include lack of diversity in both researchers and participants, lack of alignment between research institutions and the communities they serve, and lack of attention to structural sources of inequity and drivers of mistrust for science and research. The Duke University Research Equity and Diversity Initiative (READI) is a program designed to better align clinical research programs with community health priorities through community engagement. Organized around three specific aims, READI supported programs targeting increased workforce diversity, workforce training in community engagement and cultural competence, inclusive research engagement principles, and development of trustworthy partnerships.
Type
Department
Description
Provenance
Subjects
Citation
Permalink
Published Version (Please cite this version)
Publication Info
Taylor, Sally, Stephanie Freel, Lynn Sutton, Kenisha Bethea, Leatrice Martin, Julie McKeel, Matthew Ray, Perusi B Muhigaba, et al. (2025). The Research Equity and Diversity Initiative (READI): Changing the face of clinical research through community outreach and engagement. Journal of Clinical and Translational Science. pp. 1–21. 10.1017/cts.2025.10085 Retrieved from https://hdl.handle.net/10161/33065.
This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.
Collections
Scholars@Duke
Salimah El-Amin
I am a public health practitioner, researcher, and educator. My work focuses on the social determinants of health, structural factors shaping health outcomes, and persistent health inequities. I currently serve as the Assistant Director of the Center for Research, Community Engagement, Social Action and Trust (CREST). Previously, I worked at Duke University from 2015–2018 at the Samuel DuBois Cook Center on Social Equity as a Faculty Affiliate and Senior Researcher.
Denise Snyder
Facilitating clinical research support and collaborations for Duke faculty, staff, students and trainees. Revitalizing the clinical research professional workforce through innovative initiatives to improve support for clinical research that changes clinical care.
F Joseph McClernon
Joseph McClernon, Ph.D., is a professor in the Department of Psychiatry and Behavioral Sciences and founder/director of the Center for Addiction Science and Technology (CfAST). He is the Associate Director of the Duke Clinical and Translational Science Institute (CTSI). During his tenure with CTSI, his leadership has been critical to building a culture of evaluation and continuous improvement, in strengthening the institute’s partnership with North Carolina Central University and other regional partners, and in planning strategy and development for the institute.
Dr. McClernon earned a Ph.D. in clinical psychology in 2001 from Southern Illinois University-Carbondale and completed a postdoctoral fellowship at Duke in 2002. He served as Director of the Addiction Division in Psychiatry and Behavioral Sciences from 2012-2020. His research is focused on increasing our understanding of tobacco use, developing new and more effective interventions to treat nicotine dependence, and informing the FDA’s regulation of tobacco products. He has served as a site-PI and Co-I for more than ten years in the Center for the Evaluation of Nicotine in Cigarettes (CENIC)— a national consortium that has provided the bulk of evidence to the FDA for informing national policies that will reduce nicotine in cigarettes to non-addictive levels, thus saving millions of lives. Dr. McClernon is now leading efforts to transition CENIC’s focus to public health interventions that ensure the new policy will be implemented in ways that enable equitable outcomes for marginalized groups. Other regulatory science research has evaluated the effects of nicotine in cigarettes on a model of cigarette experimentation, the impact of flavors in cigarettes and e-cigarettes, and the influence of product characteristics and policy on multiple tobacco product use. He has led other groundbreaking research on the influence of drug-associated environments on drug use, relapse, and treatment; tobacco use disparities among individuals with comorbid psychiatric (e.g., ADHD, serious mental illness) and health (e.g., HIV; chronic pain) problems.
Dr. McClernon has actively mentored early career individuals from high school students through early career faculty. His former postdoctoral fellows are faculty or staff scientists at academic medical centers, government agencies, and research institutes. He has been continuously NIH-, FDA-, and foundation- funded since 2002. He has authored/co-authored more than 170 peer-reviewed publications, has two patents, has served as chair of NIH grant review panels, and is the recipient of numerous awards including the Society for Research on Nicotine and Tobacco Jarvik-Russell New Investigator Award. In 2024 he was recognized for excellence in mentoring when he was awarded the Career Mentoring Award in Clinical Research by the Duke University School of Medicine.
Michelle Jacqueline Lyn
Population Health
Community Engagement and Capacity Building
Design and implementation of collaborative disease prevention/health promotion and health care delivery models
Design and implementation of care management models
Design and implementation of educational programs for health care professionals
Keisha L. Bentley-Edwards
Dr. Keisha Bentley-Edwards is the Associate Director of Research for the Samuel DuBois Cook Center on Social Equity and an Associate Professor at Duke University’s School of Medicine, Division of General Internal Medicine. She is the Co-Director of Duke’s CTSI Center for Equity in Research. Dr. Bentley-Edwards’ research focuses on how racism, gender, and culture influence health and education outcomes throughout the lifespan, especially for African Americans. Her research emphasizes cultural strengths and eliminating structural barriers to support healthy development in communities, families, and students. Dr. Bentley-Edwards nurtures complex conversations around race and racism in ways that not only identify disparities but prompt meaningful strategies for remedying these disparities around infant and maternal health, cardiovascular disease, and kidney disease, as well as educational disparities.
Mina Ruth Silberberg
I have over thirty years of experience in health services, community health, and health policy research and evaluation. My work has focused on improving the health of low-income and otherwise underserved populations through primary care practice change, community-based programs/organizations, and addressing social drivers of health. My studies generally use mixed-methods participatory program evaluation and community-engaged research approaches. I also study, write about, and teach community engaged/participatory research and evaluation. I have a great deal of experience with mentoring trainees on research, including undergraduate students, graduate students, medical students, residents, junior faculty, and senior faculty moving into new areas of work.
Steven C. Grambow
Transforming research education through innovation, mentorship, and collaboration.
Steven C. Grambow, PhD is Associate Professor and Associate Chair of Education in the Department of Biostatistics and Bioinformatics at Duke University School of Medicine. He serves as Director of the Clinical Research Training Program (CRTP), Duke’s flagship degree-granting program for clinical and translational research education, and as Co-Director of the Workforce Development Pillar of the Duke Clinical and Translational Science Institute (CTSI). Dr. Grambow provides strategic oversight for multiple educational and workforce development initiatives that span the full continuum of learners, from students to faculty.
With over two decades of experience in graduate and professional education, Dr. Grambow has taught statistical methods and research design to more than 1,000 physician-scientists, clinical fellows, and faculty at Duke and the NIH. He has led the CRTP’s core statistics course for over 21 years and has directed or co-directed national and international certificate programs across multiple institutions. His expertise spans classroom, hybrid, and online environments, and he has served as a leader in designing programs that respond to evolving workforce and research needs.
A central focus of Dr. Grambow’s work is building pathways into clinical and translational research careers. He has cultivated longstanding partnerships with academic and community institutions, including North Carolina Central University and Durham Technical Community College, to create educational models that prepare learners for impactful roles in research. His efforts emphasize strong mentorship, practical experience, and tailored program design to meet learners where they are and help them advance.
Dr. Grambow is also at the forefront of educational innovation, leading initiatives that explore the integration of artificial intelligence into biostatistical training and academic workflows. His current work includes faculty development in AI literacy, emerging pedagogical models that support active learning and reflective practice, and new frameworks for clinical research education that emphasize adaptability and cross-disciplinary collaboration.
As a collaborative statistical scientist, Dr. Grambow has contributed to a wide range of clinical research studies, including observational studies, randomized trials, and epidemiologic investigations. His research collaborations have addressed public health and clinical challenges such as amyotrophic lateral sclerosis (ALS), post-traumatic stress disorder (PTSD), Prader-Willi syndrome (PWS), prostate cancer, cardiovascular risk reduction, and substance use recovery.
Dr. Grambow’s leadership has been recognized through institutional and national awards, including teaching honors from the American Statistical Association and Duke University. He brings a unique combination of academic rigor, educational strategy, and programmatic leadership to his roles, helping to shape the future of clinical research training through thoughtful innovation and sustained collaboration.
Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.